Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Martijn Simons, Michiel Van De Ven, Veerle Coupé, Manuela Joore, Maarten IJzerman, Erik Koffijberg, Geert Frederix, Carin Uyl - De Groot, Edwin Cuppen, Wim Van Harten & Valesca Retèl. (2021) Early technology assessment of using whole genome sequencing in personalized oncology. Expert Review of Pharmacoeconomics & Outcomes Research 21:3, pages 343-351.
Read now
Read now
M Fasihul Alam & Andrew Briggs. (2020) Artificial neural network metamodel for sensitivity analysis in a total hip replacement health economic model. Expert Review of Pharmacoeconomics & Outcomes Research 20:6, pages 629-640.
Read now
Read now
Gian-Gabriel P. Garcia, Mariel S. Lavieri, Ruiwei Jiang, Michael A. McCrea, Thomas W. McAllister & Steven P. Broglio. (2020) Data-driven stochastic optimization approaches to determine decision thresholds for risk estimation models. IISE Transactions 52:10, pages 1098-1121.
Read now
Read now
K. Degeling, M.J. IJzerman & H. Koffijberg. (2019) A scoping review of metamodeling applications and opportunities for advanced health economic analyses. Expert Review of Pharmacoeconomics & Outcomes Research 19:2, pages 181-187.
Read now
Read now
Maarten J. IJzerman, A.M. Sofie Berghuis, Johann S. de Bono & Leon W.M.M. Terstappen. (2018) Health economic impact of liquid biopsies in cancer management. Expert Review of Pharmacoeconomics & Outcomes Research 18:6, pages 593-599.
Read now
Read now
Articles from other publishers (18)
Wenjia Chen, Yi Wang, Yaroslava Zemlyanska, Dimple Butani, Nigel Chong Boon Wong, Suchin Virabhak, David Bruce Matchar & Yot Teerawattananon. (2023) Evaluating the Value for Money of Precision Medicine from Early Cycle to Market Access: A Comprehensive Review of Approaches and Challenges. Value in Health 26:9, pages 1425-1434.
Crossref
Crossref
Mussab Fagery, Hadi A. Khorshidi, Stephen Q. Wong, Martin Vu & Maarten IJzerman. (2023) Health Economic Evidence and Modeling Challenges for Liquid Biopsy Assays in Cancer Management: A Systematic Literature Review. PharmacoEconomics.
Crossref
Crossref
Carina M. Behr, Martijn J. Oude Wolcherink, Maarten J. IJzerman, Rozemarijn Vliegenthart & Hendrik Koffijberg. (2023) Population-Based Screening Using Low-Dose Chest Computed Tomography: A Systematic Review of Health Economic Evaluations. PharmacoEconomics 41:4, pages 395-411.
Crossref
Crossref
Silva Elisabete, Bessa Nuno, Mascarenhas Teresa & António Augusto Fernandes. 2023. Digital Human Modeling and Medicine. Digital Human Modeling and Medicine
213
226
.
Vivek S Chaudhari, Kanchan C Hole & Amalia M Issa. (2022) Evaluating the quality of the economic evidence in colorectal cancer genomics studies. Personalized Medicine 19:4, pages 361-375.
Crossref
Crossref
William V. Padula, Noemi Kreif, David J. Vanness, Blythe Adamson, Juan-David Rueda, Federico Felizzi, Pall Jonsson, Maarten J. IJzerman, Atul Butte & William Crown. (2022) Machine Learning Methods in Health Economics and Outcomes Research—The PALISADE Checklist: A Good Practices Report of an ISPOR Task Force. Value in Health 25:7, pages 1063-1080.
Crossref
Crossref
Martin Vu, Koen Degeling, Ella R. Thompson, Piers Blombery, David Westerman & Maarten J. IJzerman. (2022) Health economic evidence for the use of molecular biomarker tests in hematological malignancies: A systematic review. European Journal of Haematology 108:6, pages 469-485.
Crossref
Crossref
Jason Zischke, Nicole White & Louisa Gordon. (2022) Accounting for Intergenerational Cascade Testing in Economic Evaluations of Clinical Genomics: A Scoping Review. Value in Health 25:6, pages 944-953.
Crossref
Crossref
Huajie Jin, Stewart Robinson, Wenru Shang, Evanthia Achilla, David Aceituno & Sarah Byford. (2021) Overview and Use of Tools for Selecting Modelling Techniques in Health Economic Studies. PharmacoEconomics 39:7, pages 757-770.
Crossref
Crossref
Heleen Vellekoop, Simone Huygens, Matthijs Versteegh, László Szilberhorn, Tamás Zelei, Balázs Nagy, Rositsa Koleva-Kolarova, Apostolos Tsiachristas, Sarah Wordsworth & Maureen Rutten-van Mölken. (2021) Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine. PharmacoEconomics 39:7, pages 771-788.
Crossref
Crossref
Hendrik Koffijberg, Koen Degeling, Maarten J. IJzerman, Veerle M.H. Coupé & Marjolein J.E. Greuter. (2021) Using Metamodeling to Identify the Optimal Strategy for Colorectal Cancer Screening. Value in Health 24:2, pages 206-215.
Crossref
Crossref
Isaac Corro Ramos, Martine Hoogendoorn & Maureen P. M. H. Rutten-van Mölken. (2020) How to Address Uncertainty in Health Economic Discrete-Event Simulation Models: An Illustration for Chronic Obstructive Pulmonary Disease. Medical Decision Making 40:5, pages 619-632.
Crossref
Crossref
Deborah A. Marshall, Luiza R. Grazziotin, Dean A. Regier, Sarah Wordsworth, James Buchanan, Kathryn Phillips & Maarten Ijzerman. (2020) Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation Modeling. Value in Health 23:5, pages 566-573.
Crossref
Crossref
Eric Faulkner, Anke-Peggy Holtorf, Surrey Walton, Christine Y. Liu, Hwee Lin, Eman Biltaj, Diana Brixner, Charles Barr, Jennifer Oberg, Gurmit Shandhu, Uwe Siebert, Susan R. Snyder, Simran Tiwana, John Watkins, Maarten J. IJzerman & Katherine Payne. (2020) Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest Group. Value in Health 23:5, pages 529-539.
Crossref
Crossref
James Love-Koh, Alison Peel, Juan Carlos Rejon-Parrilla, Kate Ennis, Rosemary Lovett, Andrea Manca, Anastasia Chalkidou, Hannah Wood & Matthew Taylor. (2018) The Future of Precision Medicine: Potential Impacts for Health Technology Assessment. PharmacoEconomics 36:12, pages 1439-1451.
Crossref
Crossref
Koen Degeling, Maarten J. IJzerman, Miriam Koopman & Hendrik Koffijberg. (2017) Accounting for parameter uncertainty in the definition of parametric distributions used to describe individual patient variation in health economic models. BMC Medical Research Methodology 17:1.
Crossref
Crossref
Koen Degeling, Stefano Schivo, Niven Mehra, Hendrik Koffijberg, Rom Langerak, Johann S. de Bono & Maarten J. IJzerman. (2017) Comparison of Timed Automata with Discrete Event Simulation for Modeling of Biomarker-Based Treatment Decisions: An Illustration for Metastatic Castration-Resistant Prostate Cancer. Value in Health 20:10, pages 1411-1419.
Crossref
Crossref
Maarten J. IJzerman, Hendrik Koffijberg, Elisabeth Fenwick & Murray Krahn. (2017) Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the Literature. PharmacoEconomics 35:7, pages 727-740.
Crossref
Crossref